- Zacks•5 days ago
TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.
- PR Newswire•6 days ago
SAN DIEGO, Nov. 30, 2016 /PRNewswire/ -- Trovagene, Inc. (TROV), a developer of circulating tumor DNA (ctDNA) molecular diagnostics, today announced it has entered into a long-term Supply and Distribution Agreement with Boreal Genomics, merging their respective technologies to co-develop urine and blood ctDNA assay kits.
- Zacks•7 days ago
TrovaGene Inc. (TROV) recently announced encouraging data pertaining to its Precision Cancer Monitoring (PCM) technology for both urine and plasma EGFR mutation testing.
TROV : Summary for TrovaGene, Inc. - Yahoo Finance
TrovaGene, Inc. (TROV)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.45 x 7200|
|Ask||2.50 x 3900|
|Day's Range||2.45 - 2.65|
|52 Week Range||2.45 - 6.93|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.92|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|